LexAurum Advisors LLC Sells 228 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

LexAurum Advisors LLC trimmed its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,090 shares of the company’s stock after selling 228 shares during the quarter. LexAurum Advisors LLC’s holdings in GE HealthCare Technologies were worth $759,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of GEHC. Wellington Management Group LLP grew its stake in shares of GE HealthCare Technologies by 575.6% during the fourth quarter. Wellington Management Group LLP now owns 21,118 shares of the company’s stock worth $1,633,000 after buying an additional 17,992 shares during the last quarter. Fisher Asset Management LLC grew its stake in shares of GE HealthCare Technologies by 12.6% during the fourth quarter. Fisher Asset Management LLC now owns 4,775 shares of the company’s stock worth $369,000 after buying an additional 535 shares during the last quarter. Nomura Holdings Inc. bought a new stake in shares of GE HealthCare Technologies during the fourth quarter worth $610,000. Mather Group LLC. bought a new stake in shares of GE HealthCare Technologies during the first quarter worth $106,000. Finally, Rise Advisors LLC grew its stake in shares of GE HealthCare Technologies by 241.4% during the first quarter. Rise Advisors LLC now owns 338 shares of the company’s stock worth $31,000 after buying an additional 239 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC stock opened at $90.82 on Friday. The company’s fifty day simple moving average is $87.75 and its 200 day simple moving average is $83.41. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.55. The firm has a market cap of $41.46 billion, a price-to-earnings ratio of 26.56, a PEG ratio of 3.39 and a beta of 1.18. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The company had revenue of $4.84 billion for the quarter, compared to analyst estimates of $4.88 billion. During the same quarter in the prior year, the business posted $0.92 EPS. The firm’s revenue was up .5% compared to the same quarter last year. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a $0.03 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price objective for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. Stifel Nicolaus boosted their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a “buy” rating in a research note on Monday, September 30th. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a research note on Wednesday, September 18th. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective on the stock. Finally, Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research note on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and a consensus target price of $94.23.

Insider Buying and Selling

In related news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.27% of the stock is currently owned by company insiders.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.